Sensitivity analysis of parallel trend with relative deviation limits. by Pu Miao (12886949)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the N6, tZr, tZ, and cZ content of HHZ and XLY900 at 24h under saline conditions. by Yin Jie (21464235)

Subjects:

Instrumental variable regression results. by Pu Miao (12886949)

Subjects:

Other robust regression results. by Pu Miao (12886949)

Subjects:

Flowchart of the study population. by Alejandro Rojas Chaves (20614814)

Subjects:

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). by Jinho Lee (587173)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the root morphologies of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects:

Whole genome sequencing map of the intron 25-exon 26 transition of the murine <i>Tg</i> locus. by Wendy J. Bailey (14926392)

Subjects:

Genotype-based analysis of the LINE-1. by Wendy J. Bailey (14926392)

Subjects:

RNA analysis reveals a ~6-fold reduced coverage of exon 26 in the murine <i>Tg</i> gene. by Wendy J. Bailey (14926392)

Subjects:

Characteristics of participants with an asymptomatic malaria infection: Overall and by anemia status (n = 393). by Alejandro Rojas Chaves (20614814)

Subjects:

Correlation of H-scores of AR and ER expression in the peripheral lobules {STT (r = 0.95) and the LTT groups (r = 0.90)}. by Jinho Lee (587173)

Subjects:

A schematic mechanism of 1’,4’-<i>trans</i>-diol-ABA in response to salt stress in rice seedlings. by Yin Jie (21464235)

Subjects:

Body weight (BW) measurements. by Wendy J. Bailey (14926392)

Subjects:

Baseline regression results. by Pu Miao (12886949)

Subjects:

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the dry weight of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Subjects:

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

Subjects:

Results of propensity score matching. by Pu Miao (12886949)

Subjects: